Literature DB >> 1877886

A comparison of the sensitivity and specificity of sialodacryoadenitis virus, Parker's rat coronavirus, and mouse hepatitis virus-infected cells as a source of antigen for the detection of antibody to rat coronaviruses.

D H Percy1, K L Williams, F X Paturzo.   

Abstract

Sialodacryoadenitis virus (SDAV) and Parker's rat coronavirus (PRC) are two recognized viral strains which cause spontaneous disease in the laboratory rat. Currently there is no recognized practical procedure which will accurately differentiate infections with these strains. Using SDAV- and PRC-infected L-2 cells as the source of antigen, and sera from rats collected post inoculation with either of these viral strains, the indirect fluorescent antibody (IFA) procedure was used to determine whether antibody titers could be used to differentiate infections from the homologous and heterologous virus. There was no detectable difference in the sensitivity or specificity of these systems in detecting antibody to the homologous or heterologous virus. Thus there was no evidence that SDAV- and PRC-infected cells would serve to differentiate antibody to the homologous virus using the IFA technique. In addition, antibody titers were similar when mouse hepatitis virus (MHV)-infected cells were used as the source of antigen for the IFA technique. However, using MHV or SDAV-infected cells as the source of antigen, there was a significant difference in antibody titers to the homologous virus detected using the immunoenzyme technique.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1877886      PMCID: PMC7087136          DOI: 10.1007/bf01310668

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  7 in total

1.  Characterization of the virus of sialodacryoadenitis of rats: a member of the coronavirus group.

Authors:  P N Bhatt; D H Percy; A M Jonas
Journal:  J Infect Dis       Date:  1972-08       Impact factor: 5.226

2.  An immunofluorescence test for detection of serum antibody to rodent coronaviruses.

Authors:  A L Smith
Journal:  Lab Anim Sci       Date:  1983-04

3.  Two enzyme immunoassays for the detection of antibody to rodent coronaviruses.

Authors:  A L Smith; D F Winograd
Journal:  J Virol Methods       Date:  1986-11       Impact factor: 2.014

4.  Sialodacryoadenitis virus-associated lesions in the lower respiratory tract of rats.

Authors:  Z W Wojcinski; D H Percy
Journal:  Vet Pathol       Date:  1986-05       Impact factor: 2.221

5.  Replication of sialodacryoadenitis virus in mouse L-2 cells.

Authors:  D Percy; S Bond; J MacInnes
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

6.  Characteristics of Parker's rat coronavirus (PRC) replicated in L-2 cells.

Authors:  D H Percy; K L Williams; S J Bond; J I MacInnes
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

7.  Rat coronavirus (RCV): a prevalent, naturally occurring pneumotropic virus of rats.

Authors:  J C Parker; S S Cross; W P Rowe
Journal:  Arch Gesamte Virusforsch       Date:  1970
  7 in total
  4 in total

1.  Preliminary characterization of the structural proteins of the coronaviruses, sialodacryoadenitis virus and Parker's rat coronavirus.

Authors:  M G Barker; D H Percy; D J Hovland; J I MacInnes
Journal:  Can J Vet Res       Date:  1994-04       Impact factor: 1.310

2.  Primary structure of the sialodacryoadenitis virus genome: sequence of the structural-protein region and its application for differential diagnosis.

Authors:  D Yoo; Y Pei; N Christie; M Cooper
Journal:  Clin Diagn Lab Immunol       Date:  2000-07

3.  Coronavirus infections in the laboratory rat: degree of cross protection following immunization with a heterologous strain.

Authors:  C G Bihun; D H Percy
Journal:  Can J Vet Res       Date:  1994-07       Impact factor: 1.310

4.  Rat coronaviruses infect rat alveolar type I epithelial cells and induce expression of CXC chemokines.

Authors:  Tanya A Miura; Jieru Wang; Kathryn V Holmes; Robert J Mason
Journal:  Virology       Date:  2007-09-05       Impact factor: 3.616

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.